SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.
COVID-19
Diabetes mellitus
MERS
SARS
SARS-CoV-2
hypertension
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
30 09 2020
30 09 2020
Historique:
received:
30
04
2020
accepted:
07
09
2020
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
29
10
2020
Statut:
ppublish
Résumé
After the emergence of the novel 2019 coronavirus disease in P. R. China, this highly contagious disease has been currently spread out to almost all countries, worldwide. Novel 2019 coronavirus disease, Middle East respiratory syndrome, and severe acute respiratory syndrome are reported to cause a higher risk for severe infections in patients with chronic comorbidities, such as hypertension and diabetes. These severe infections can contribute to higher rates of morbidity and mortality in these patients. In the present review, we discussed the role and underlying mechanisms of the two most common chronic diseases, type-2 diabetes mellitus and hypertension, in clinical manifestations and disease severity of novel 2019 coronavirus disease, Middle East respiratory syndrome and severe acute respiratory syndrome, with the hope to provide evidence for better decision-making in the treatment of this vulnerable population.
Identifiants
pubmed: 33070543
pii: 1601434243823-1006603597
doi: 10.31083/j.rcm.2020.03.78
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
385-397Informations de copyright
© 2020 Deravi et al. Published by IMR press.
Déclaration de conflit d'intérêts
All authors declare no conflicts of interest.